Linn SC - Search Results

1

Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.

Steenbruggen TG, van Ramshorst MS, Kok M, Linn SC, Smorenburg CH, Sonke GS. Steenbruggen TG, et al. Among authors: linn sc. Drugs. 2017 Aug;77(12):1313-1336. doi: 10.1007/s40265-017-0774-5. Drugs. 2017. PMID: 28616845 Review.

2

Multidrug resistance in breast cancer: mechanisms, strategies.

Giaccone G, Linn SC, Pinedo HM. Giaccone G, et al. Among authors: linn sc. Eur J Cancer. 1995;31A Suppl 7:S15-7. doi: 10.1016/0959-8049(95)00293-r. Eur J Cancer. 1995. PMID: 8562185 Review. No abstract available.

3

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.

Honkoop AH, van Diest PJ, de Jong JS, Linn SC, Giaccone G, Hoekman K, Wagstaff J, Pinedo HM. Honkoop AH, et al. Among authors: linn sc. Br J Cancer. 1998 Feb;77(4):621-6. doi: 10.1038/bjc.1998.99. Br J Cancer. 1998. PMID: 9484820 Free PMC article.

4

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.

Kok M, Linn SC, Van Laar RK, Jansen MP, van den Berg TM, Delahaye LJ, Glas AM, Peterse JL, Hauptmann M, Foekens JA, Klijn JG, Wessels LF, Van't Veer LJ, Berns EM. Kok M, et al. Among authors: linn sc. Breast Cancer Res Treat. 2009 Jan;113(2):275-83. doi: 10.1007/s10549-008-9939-y. Epub 2008 Mar 4. Breast Cancer Res Treat. 2009. PMID: 18311582

5

Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.

Holm C, Kok M, Michalides R, Fles R, Koornstra RH, Wesseling J, Hauptmann M, Neefjes J, Peterse JL, Stål O, Landberg G, Linn SC. Holm C, et al. Among authors: linn sc. J Pathol. 2009 Feb;217(3):372-9. doi: 10.1002/path.2455. J Pathol. 2009. PMID: 18991335

6

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

Straver ME, van Adrichem JC, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Gilhuijs KG, Oldenburg HS, Wesseling J, Russell NS, Antonini N, Vrancken Peeters MT. Straver ME, et al. Among authors: linn sc. Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2519-25. Ned Tijdschr Geneeskd. 2008. PMID: 19055260 Dutch.

7

Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.

Kok M, Koornstra RH, Margarido TC, Fles R, Armstrong NJ, Linn SC, Van't Veer LJ, Weigelt B. Kok M, et al. Among authors: linn sc. J Pathol. 2009 Jul;218(3):316-26. doi: 10.1002/path.2544. J Pathol. 2009. PMID: 19353633

8

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.

Bueno-de-Mesquita JM, Nuyten DS, Wesseling J, van Tinteren H, Linn SC, van de Vijver MJ. Bueno-de-Mesquita JM, et al. Among authors: linn sc. Ann Oncol. 2010 Jan;21(1):40-7. doi: 10.1093/annonc/mdp273. Epub 2009 Jul 21. Ann Oncol. 2010. PMID: 19622588 Free article.

9

A simple system for grading the response of breast cancer to neoadjuvant chemotherapy.

Rodenhuis S, Mandjes IAM, Wesseling J, van de Vijver MJ, Peeters MTDFV, Sonke GS, Linn SC. Rodenhuis S, et al. Among authors: linn sc. Ann Oncol. 2010 Mar;21(3):481-487. doi: 10.1093/annonc/mdp348. Epub 2009 Aug 28. Ann Oncol. 2010. PMID: 19717533 Free article.

10

Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept.

Linn SC, Van 't Veer LJ. Linn SC, et al. Eur J Cancer. 2009 Sep;45 Suppl 1:11-26. doi: 10.1016/S0959-8049(09)70012-7. Eur J Cancer. 2009. PMID: 19775601 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters